Works matching DE "ENFUVIRTIDE (Drug)"
Results: 36
Section: bioprocessing and biological engineering gene fragment polymerization for increased yield of recombinant HIV fusion inhibitor enfuvirtide.
- Published in:
- Biotechnology Letters, 2014, v. 36, n. 9, p. 1761, doi. 10.1007/s10529-014-1556-8
- By:
- Publication type:
- Article
Erratum to: Gene fragment polymerization for increased yield of recombinant HIV fusion inhibitor Enfuvirtide.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.
- Published in:
- HIV Medicine, 2011, v. 12, n. 2, p. 65, doi. 10.1111/j.1468-1293.2010.00848.x
- By:
- Publication type:
- Article
The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy.
- Published in:
- HIV Medicine, 2011, v. 12, n. 1, p. 31, doi. 10.1111/j.1468-1293.2010.00845.x
- By:
- Publication type:
- Article
Genetic and Structural Analysis of HIV-1 Rev Responsive Element Related to V38A and T18A Enfuvirtide Resistance Mutations.
- Published in:
- Intervirology, 2012, v. 55, n. 5, p. 385, doi. 10.1159/000334696
- By:
- Publication type:
- Article
Nodular amyloidosis at the sites of insulin injections.
- Published in:
- Journal of Cutaneous Pathology, 2015, v. 42, n. 7, p. 496, doi. 10.1111/cup.12501
- By:
- Publication type:
- Article
A Novel Form of Amyloid Deposited at the Site of Enfuvirtide Injection.
- Published in:
- Journal of Cutaneous Pathology, 2012, v. 39, n. 2, p. 220, doi. 10.1111/j.1600-0560.2012.01865_2.x
- By:
- Publication type:
- Article
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 3, p. 690
- By:
- Publication type:
- Article
Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2099
- By:
- Publication type:
- Article
Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 Substudy.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 6, p. 892, doi. 10.1093/infdis/jit280
- By:
- Publication type:
- Article
Fuzeon-Induced Collagenophagic Granuloma: A Peculiar Granulomatous Injection Site Reaction to Fuzeon- A Case Report and Review of Literature.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.
- Published in:
- AIDS Research & Therapy, 2016, p. 1, doi. 10.1186/S12981-016-0101-3
- By:
- Publication type:
- Article
Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naïve Korean patients.
- Published in:
- Archives of Virology, 2016, v. 161, n. 6, p. 1547, doi. 10.1007/s00705-016-2807-x
- By:
- Publication type:
- Article
Mathematical Modelling of Enfuvirtide and Protease Inhibitors as Combination Therapy for HIV.
- Published in:
- International Journal of Nonlinear Sciences & Numerical Simulation, 2016, v. 17, n. 6, p. 259, doi. 10.1515/ijnsns-2015-0051
- By:
- Publication type:
- Article
Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 11, p. 1, doi. 10.1371/journal.ppat.1005983
- By:
- Publication type:
- Article
Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 5, p. 439, doi. 10.3390/v11050439
- By:
- Publication type:
- Article
Short-course intensification with enfuvirtide in virologic failure: impact on intracellular HIV reservoir and on viral tropism (INNOVE study).
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P40, doi. 10.1186/1758-2652-13-S4-P40
- By:
- Publication type:
- Article
Enfuvirtide in therapy at patients with HIV-infection and tuberculosis.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P197, doi. 10.1186/1758-2652-13-S4-P197
- By:
- Publication type:
- Article
Short-course intensification with enfuvirtide in virologic failure: impact on intracellular HIV reservoir and on viral tropism (INNOVE study).
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Relapse of Intravenous Drug Use Triggered by Enfuvirtide, a Parenteral Antiretroviral Medication.
- Published in:
- AIDS Patient Care & STDs, 2012, v. 26, n. 2, p. 71, doi. 10.1089/apc.2011.0343
- By:
- Publication type:
- Article
Antiviral Briefs.
- Published in:
- AIDS Patient Care & STDs, 2010, v. 24, n. 12, p. 805, doi. 10.1089/apc.2010.9890
- Publication type:
- Article
Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1.
- Published in:
- FASEB Journal, 2012, v. 26, n. 11, p. 4628, doi. 10.1096/fj.12-215111
- By:
- Publication type:
- Article
Improved Pharmacological and Structural Properties of HIV Fusion Inhibitor AP3 over Enfuvirtide: Highlighting Advantages of Artificial Peptide Strategy.
- Published in:
- Scientific Reports, 2015, p. 13028, doi. 10.1038/srep13028
- By:
- Publication type:
- Article
The improved efficacy of Sifuvirtide compared with enfuvirtide might be related to its selectivity for the rigid biomembrane, as determined through surface plasmon resonance.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0171567
- By:
- Publication type:
- Article
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.
- Published in:
- Infection, 2012, v. 40, n. 1, p. 69, doi. 10.1007/s15010-011-0223-4
- By:
- Publication type:
- Article
A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.
- Published in:
- Molecules, 2019, v. 24, n. 6, p. 1134, doi. 10.3390/molecules24061134
- By:
- Publication type:
- Article
Action of enfuvirtide on the pregnancy of albino rats (Rattus norvegicus albinus, Rodentia, Mammalia): biological assay and functional and histological analyses of exposed maternal-fetal organs.
- Published in:
- Einstein (16794508), 2023, v. 21, p. 1, doi. 10.31744/einstein_journal/2023AO0230
- By:
- Publication type:
- Article
Pharmacokinetic profile in late pregnancy and cord blood concentration of tipranavir and enfuvirtide.
- Published in:
- International Journal of STD & AIDS, 2011, v. 22, n. 5, p. 294, doi. 10.1258/ijsa.2009.009166
- By:
- Publication type:
- Article
HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0206365
- By:
- Publication type:
- Article
Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production.
- Published in:
- Microbial Cell Factories, 2016, v. 15, p. 1, doi. 10.1186/s12934-016-0502-y
- By:
- Publication type:
- Article
Modelling two different therapy strategies for drug T-20 on HIV-1 patients.
- Published in:
- Applied Mathematics & Mechanics, 2011, v. 32, n. 4, p. 419, doi. 10.1007/s10483-011-1427-8
- By:
- Publication type:
- Article
Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060302
- By:
- Publication type:
- Article
A Compensatory Mutation Provides Resistance to Disparate HIV Fusion Inhibitor Peptides and Enhances Membrane Fusion.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055478
- By:
- Publication type:
- Article
A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041235
- By:
- Publication type:
- Article
Impact of the HIV-1 env Genetic Context outside HR1-HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0021535
- By:
- Publication type:
- Article
Susceptibility of HIV-1 Subtypes B9, CRF07BC and CRF01AE that Are Predominantly Circulating in China to HIV-1 Entry Inhibitors.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017605
- By:
- Publication type:
- Article